✦ LIBER ✦

Recombinant vaccinia virus expressing gB glycoprotein from herpes-simplex virus-1 useful for recombinant vaccine production

Book ID: 119150480
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 135 KB
Volume: 7
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(89)90211-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of herpes simplex virus type

Expression of herpes simplex virus type 1 DNA polymerase by recombinant vaccinia virus

✍ Ralf Kronenwett; Klaus Weisshart; Charles W. Knopf 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 440 KB

Herpes virus recombinant pox virus recom

Herpes virus recombinant pox virus recombinant vaccine; recombinant vaccinia virus, canary-pox virus, fowl-pox virus construction by insertion of glycoprotein gene from foreign herpes virus, pseudorabies virus, Epstein-Barr virus or cytomegalovirus

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Recombinant baculovirus production for r

Recombinant baculovirus production for recombinant herpes simplex virus-1 glycoprotein-I expression in Spodoptera frugiperda insect cell culture using plasmid pAG-G11; application in recombinant vaccine production

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Herpes simplex virus-1 deletion variant;

Herpes simplex virus-1 deletion variant; use in herpes virus-2, human cytomegalovirus or HIV virus-1 or -2 recombinant vaccine production

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Recombinant vaccinia virus expressing AI

Recombinant vaccinia virus expressing AIDS envelope protein inducing antibodies specific for HIV virus III; potentially useful for vaccine

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 147 KB

From virus to vaccine: Recombinant mamma

From virus to vaccine: Recombinant mammalian cell lines as substrates for the production of herpes simplex virus vaccines

✍ Laurence A. Lasky 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

## Abstract The use of mammalian cells as substrates for the production of various vaccines is a time‐honored procedure. With the advent of recombinant DNA technology, various investigators soon realized that these techniques could be applied to mammalian cells to convert them to reliable, safe pro